Solutions

Solutions

Delivering Pharma’s only comprehensive data, consulting, and business process platform for market access

Transforming Access from Strategy to Operational Execution

From helping emerging companies plan and execute their first-time launch, to supporting more than 65% of the Top 50 largest manufacturers, IntegriChain’s solutions have helped manufacturers unify market access teams and solve complex market access business challenges.

Through IntegriChain’s ICyte platform, historically siloed Market Access functions – commercial teams focused on payers and patient access; operational teams focused on contract management and pricing; and finance teams focused on gross-to-net forecasting and accruals – are able to come together through shared data, eliminating manual processes and disparate system that often hold these teams back from innovating and transforming access to their therapies.

From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization

Featured Solution

Webinar

State Price Transparency: 2022 Legislative and Regulatory Overview

IntegriChain subject matter experts discuss the current status of drug pricing transparency laws that have been recently introduced and updated at the state level. Topics include disclosures themes, types of reports, and new reporting updates for nearly a dozen states.
Watch THE WEBINAR

 Paper

The Case for Gross-to-Net Automation

As the GTN bubble grows, so does increased stakeholder scrutiny on GTN analytics. Although the industry is moving toward automation, many life sciences manufacturers are currently analyzing their options, the value automation brings to the organization, and making a business case to management.
READ Paper

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand